Logo

Bio-Rad's Clinical Dx Revenues Rise 18 Percent As Sales Improve Across the Board

Nov 07, 2007
NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said third-quarter revenues increased 11 percent as R&D spending rose 7 percent and profit jumped around 20 percent.
 
Total receipts for the three months ended Sept. 30 increased to $339.7 million from $304.8 million year over year.
 
Revenue from the company’s Clinical Diagnostics segment rose nearly 18 percent to $193.3 million as it experienced “strong growth across all product lines, particularly in quality control, auto-immune, diabetes, and blood virus testing products.”
 
Meantime, receipts from the Life Science division grew 4.1 percent to $143 million in part due to sales of its recently released ProteOn XPR36 protein interaction array system as well as the Bio-Plex suspension array systems and reagents.
 
R&D spending rose to $33.1 million from $31 million year over year.
 
Bio-Rad's profit jumped to $28 million from $23.2 million in the year-ago period.
 
Bio-Rad said it had around $472.8 million in cash and equivalents and $70.6 million in short-term investments as of Sept. 30.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.